Literature DB >> 15090139

High throughput ion-channel pharmacology: planar-array-based voltage clamp.

Laszlo Kiss1, Paul B Bennett, Victor N Uebele, Kenneth S Koblan, Stefanie A Kane, Brad Neagle, Kirk Schroeder.   

Abstract

Technological advances often drive major breakthroughs in biology. Examples include PCR, automated DNA sequencing, confocal/single photon microscopy, AFM, and voltage/patch-clamp methods. The patch-clamp method, first described nearly 30 years ago, was a major technical achievement that permitted voltage-clamp analysis (membrane potential control) of ion channels in most cells and revealed a role for channels in unimagined areas. Because of the high information content, voltage clamp is the best way to study ion-channel function; however, throughput is too low for drug screening. Here we describe a novel breakthrough planar-array-based HT patch-clamp technology developed by Essen Instruments capable of voltage-clamping thousands of cells per day. This technology provides greater than two orders of magnitude increase in throughput compared with the traditional voltage-clamp techniques. We have applied this method to study the hERG K(+) channel and to determine the pharmacological profile of QT prolonging drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15090139     DOI: 10.1089/154065803321537845

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  18 in total

1.  A novel method for patch-clamp automation.

Authors:  D Vasilyev; T Merrill; A Iwanow; J Dunlop; M Bowlby
Journal:  Pflugers Arch       Date:  2006-04-05       Impact factor: 3.657

2.  Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG-encoded potassium channel.

Authors:  Roope Männikkö; G Overend; C Perrey; C L Gavaghan; J-P Valentin; J Morten; M Armstrong; C E Pollard
Journal:  Br J Pharmacol       Date:  2009-08-10       Impact factor: 8.739

3.  Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.

Authors:  Menghang Xia; Sampada A Shahane; Ruili Huang; Steven A Titus; Enoch Shum; Yong Zhao; Noel Southall; Wei Zheng; Kristine L Witt; Raymond R Tice; Christopher P Austin
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-26       Impact factor: 4.219

Review 4.  Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Karim Sallam; Yingxin Li; Philip T Sager; Steven R Houser; Joseph C Wu
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

5.  Bioluminescence methodology for the detection of protein-protein interactions within the voltage-gated sodium channel macromolecular complex.

Authors:  Alexander Shavkunov; Neli Panova; Anesh Prasai; Ron Veselenak; Nigel Bourne; Svetla Stoilova-McPhie; Fernanda Laezza
Journal:  Assay Drug Dev Technol       Date:  2012-02-24       Impact factor: 1.738

6.  hERG subunit composition determines differential drug sensitivity.

Authors:  N Abi-Gerges; H Holkham; E M C Jones; C E Pollard; J-P Valentin; G A Robertson
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

7.  An air-molding technique for fabricating PDMS planar patch-clamp electrodes.

Authors:  Kathryn G Klemic; James F Klemic; Fred J Sigworth
Journal:  Pflugers Arch       Date:  2004-12-01       Impact factor: 3.657

8.  Tuning HERG out: antitarget QSAR models for drug development.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Alexander Tropsha; Carolina H Andrade
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

9.  Protein-Protein Interactions as New Targets for Ion Channel Drug Discovery.

Authors:  Svetla Stoilova-McPhie; Syed Ali; Fernanda Laezza
Journal:  Austin J Pharmacol Ther       Date:  2013-12-31

10.  Identification of Ikr kinetics and drug binding in native myocytes.

Authors:  Qinlian Zhou; Andrew C Zygmunt; Jonathan M Cordeiro; Fernando Siso-Nadal; Robert E Miller; Gregery T Buzzard; Jeffrey J Fox
Journal:  Ann Biomed Eng       Date:  2009-04-08       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.